TG 02 in patients with solid tumours.
Phase of Trial: Phase I
Latest Information Update: 29 Nov 2012
At a glance
- Drugs TG 02 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 29 Nov 2012 Status changed from unconfirmed to planning.
- 27 Nov 2012 no mention of solid tumour trials planned in latest MR, 9144046
- 13 Sep 2010 New trial record